Fig. 4From: Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma ConsortiumDevelopment of new overall prognostic models. The OS prognostic model was developed in the training cohort (A) and tested in the validation cohort (B). The PFS prognostic model was developed in the training cohort (C) and tested in the validation cohort (D)Back to article page